192 related articles for article (PubMed ID: 29589280)
1. Response to cyclosporine A and corticosteroids in adult patients with acquired pure red cell aplasia: serial experience at a single center.
Wu X; Wang S; Lu X; Shen W; Qiao C; Wu Y; Lu R; Wang S; Zhang J; Hong M; Zhu Y; Li J; He G
Int J Hematol; 2018 Aug; 108(2):123-129. PubMed ID: 29589280
[TBL] [Abstract][Full Text] [Related]
2. Induced complete remission faster in adult patients with acquired pure red cell aplasia by combining cyclosporine A with corticosteroids.
Wu X; Yang Y; Lu X; Yin H; Wang S; Wang S; Hong M; Zhu Y; Lu R; Qiao C; Wu Y; He G; Li J
Medicine (Baltimore); 2019 Oct; 98(41):e17425. PubMed ID: 31593095
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group.
Sawada K; Hirokawa M; Fujishima N; Teramura M; Bessho M; Dan K; Tsurumi H; Nakao S; Urabe A; Omine M; Ozawa K;
Haematologica; 2007 Aug; 92(8):1021-8. PubMed ID: 17640861
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive therapy for elderly-acquired pure red cell aplasia: cyclosporine A may be more effective.
Liu X; Lu X; Chen L; Yang Y; Wu X; Lu R; Wang S; Zhang J; Hong M; Zhu Y; He G; Li J
Ann Hematol; 2020 Mar; 99(3):443-449. PubMed ID: 31970447
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of Cyclosporine A and Cyclosporine A Combined with Corticosteroid in the Treatment of Acquired Pure Red Cell Aplasia].
Zhang RX; Huang YZ; Han B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1138-1142. PubMed ID: 37551489
[TBL] [Abstract][Full Text] [Related]
6. Clinical use of cyclosporine as an adjunctive therapy in the management of feline idiopathic pure red cell aplasia.
Viviano KR; Webb JL
J Feline Med Surg; 2011 Dec; 13(12):885-95. PubMed ID: 21900029
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporine restores hematopoietic function by compensating for decreased Tregs in patients with pure red cell aplasia and acquired aplastic anemia.
Dao AT; Yamazaki H; Takamatsu H; Sugimori C; Katagiri T; Maruyama H; Zaimoku Y; Maruyama K; Ly TQ; Espinoza L; Nakao S
Ann Hematol; 2016 Apr; 95(5):771-81. PubMed ID: 26968551
[TBL] [Abstract][Full Text] [Related]
8. Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: a nationwide cohort study in Japan by the PRCA collaborative study group.
Hirokawa M; Sawada K; Fujishima N; Nakao S; Urabe A; Dan K; Fujisawa S; Yonemura Y; Kawano F; Omine M; Ozawa K;
Haematologica; 2008 Jan; 93(1):27-33. PubMed ID: 18166782
[TBL] [Abstract][Full Text] [Related]
9. Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: a Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group.
Fujishima N; Sawada K; Hirokawa M; Oshimi K; Sugimoto K; Matsuda A; Teramura M; Karasawa M; Arai A; Yonemura Y; Nakao S; Urabe A; Omine M; Ozawa K;
Haematologica; 2008 Oct; 93(10):1555-9. PubMed ID: 18641028
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and outcomes of 100 adult patients with pure red cell aplasia.
Wu X; Cheng L; Liu X; Sun Y; Li B; He G; Li J
Ann Hematol; 2022 Jul; 101(7):1493-1498. PubMed ID: 35460389
[TBL] [Abstract][Full Text] [Related]
11. The clinical characteristics and therapy response of patients with acquired pure red cell aplasia.
Fu R; Zhang T; Liu B; Song J; Wang G; Li L; Wang H; Xing L; Wu Y; Guan J; Shao Z
Hematology; 2018 Oct; 23(9):639-645. PubMed ID: 29754581
[TBL] [Abstract][Full Text] [Related]
12. Successful sirolimus treatment of patients with pure red cell aplasia complicated with renal insufficiency.
Chen Z; Liu X; Chen M; Yang C; Han B
Ann Hematol; 2020 Apr; 99(4):737-741. PubMed ID: 32030447
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and outcomes of 11 patients with pure red cell aplasia at a single institution over a 13-year period.
Kawano N; Nagahiro Y; Yoshida S; Yamashita K; Himeji D; Yokota-Ikeda N; Uezono S; Shimao Y; Makino S; Shimoda K; Ueda A
Intern Med; 2013; 52(18):2025-30. PubMed ID: 24042508
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of patients with acquired chronic pure red cell aplasia (PRCA) following immunosuppressive therapy: a final report of the nationwide cohort study in 2004/2006 by the Japan PRCA collaborative study group.
Hirokawa M; Sawada K; Fujishima N; Teramura M; Bessho M; Dan K; Tsurumi H; Nakao S; Urabe A; Fujisawa S; Yonemura Y; Kawano F; Oshimi K; Sugimoto K; Matsuda A; Karasawa M; Arai A; Komatsu N; Harigae H; Omine M; Ozawa K; Kurokawa M;
Br J Haematol; 2015 Jun; 169(6):879-86. PubMed ID: 25807974
[TBL] [Abstract][Full Text] [Related]
15. Acquired pure red cell aplasia: updated review of treatment.
Sawada K; Fujishima N; Hirokawa M
Br J Haematol; 2008 Aug; 142(4):505-14. PubMed ID: 18510682
[TBL] [Abstract][Full Text] [Related]
16. Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes.
Go RS; Li CY; Tefferi A; Phyliky RL
Blood; 2001 Jul; 98(2):483-5. PubMed ID: 11435321
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporin A for the treatment of pure red cell aplasia associated with myelodysplasia.
Grigg AP; O'Flaherty E
Leuk Lymphoma; 2001; 42(6):1339-42. PubMed ID: 11911417
[TBL] [Abstract][Full Text] [Related]
18. Treatment of refractory pure red cell aplasia with cyclosporine A: disappearance of IgG inhibitor associated with clinical response.
Means RT; Dessypris EN; Krantz SB
Br J Haematol; 1991 May; 78(1):114-9. PubMed ID: 1904268
[TBL] [Abstract][Full Text] [Related]
19. Treatment of pure red-cell aplasia and aplastic anaemia with ciclosporin: long-term clinical effects.
Tötterman TH; Höglund M; Bengtsson M; Simonsson B; Almqvist D; Killander A
Eur J Haematol; 1989 Feb; 42(2):126-33. PubMed ID: 2492947
[TBL] [Abstract][Full Text] [Related]
20. A case report of a patient who has pure red cell aplasia and rheumatoid arthritis.
Ustün C; Karavelioğlu D; Ilhan O; Aydintuğ O; Beksaç M
Int J Hematol; 1997 Dec; 66(4):505-12. PubMed ID: 9479876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
